mRNA Vaccine and Therapeutics Market 2021-26: Industry Growth, Size, Share, Analysis and Forecast

SHERIDAN, Wyo. - Aug. 22, 2021 - PRLog -- According to IMARC Group's latest report, the global mRNA vaccines and therapeutics market potential is expected to reach a value of US$ 9.41 Billion in 2021. Looking forward, the market is projected to register a CAGR of 10.5% during 2021-2026, reaching a value of US$ 15.49 Billion by 2026.

The messenger ribonucleic acid, or mRNA, refers to a protein-coding gene in the genome that provides a basis for protein synthesis within the cells. The mRNA vaccines and therapeutics include self-amplifying, in-vivo self-replicating, and in-vitro dendritic cell non-replicating mRNA that combine the desirable immunological properties. These vaccines are usually injected into the body to trigger virus-detecting immune sensors and produce viral antigen protein cells, which aid in enhancing the immunity of the body by improving B- and T- cell responses.

Market Trends

The mRNA vaccines are more effective against pathogens, cost-efficient, and have enhanced immunogenicity and higher potency. As a result, leading players are focusing on the development of an mRNA-based vaccine for the coronavirus disease (COVID-19). The success of the vaccine for COVID-19 can potentially boost the market growth. Along with this, improvements in healthcare technologies, such as the development of lipid nanoparticle formulations for in-vivo systemic delivery of mRNA, is providing a positive impact on the industry.

Request Free Sample Report: https://www.imarcgroup.com/mrna-vaccines-therapeutics-market/requestsample

List of Key Companies Covered in this Market Report:

• Argos Therapeutics Inc. (SCM Life Science and Genexine)
• AstraZeneca
• Bayer AG
• BioNTech AG
• Boehringer Ingelheim
• CRISPR Therapeutics
• CureVac AG
• eTheRNA Immunotherapies
• Ethris GmbH
• In-Cell-Art
• Intellia Therapeutics Inc.
• Moderna Therapeutics
• Sangamo Therapeutics
• Tiba Biotech LLC
• Translate Bio Inc.

Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/mrna-vaccines-therapeutics-market

The report has segmented the market on the basis of vaccine type, treatment type, vaccine manufacturing, application, end-user and geography.

Breakup by Vaccine Type:

• Self-amplifying mRNA-based Vaccines
• Conventional Non-Amplifying mRNA-Based Vaccines
• Others

Breakup by Treatment Type:

• Bioengineered Vaccine Based Treatment
• Gene Therapy (Gene Silencing/Suppression)
• Gene Transcription (Protein Generation)
• Cell Therapy
• Monoclonal Antibody Based Treatment
• Others

Breakup by Vaccine Manufacturing:

• In-House mRNA Vaccine Manufacturing
• Out-Sourced mRNA Vaccine Manufacturing

Breakup by Application:

• Cancer
• Infectious Disease
• Vaccines In-vivo Therapeutics
• Gene Editing
• Others

Breakup by End-User:

• Hospitals and Clinics
• Research Organizations
• Others

Contact US:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800